← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dimera, Inc.
Portland, OR
$4,650,758
Total funding
5
Grants
Funding mix
By agency
NIH$4,650,758 · 5
By mechanism
R44$2,861,251 · 2
R01$1,530,750 · 1
R43$258,757 · 2
Investigators at Dimera, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
ER beta selective agonist coronary protection-menopause$958,300
R44 · FY2004 · HL
ER beta selective agonist coronary protection-menopause$893,450
R44 · FY2005 · HL
HORMONE REPLACEMENT THERAPY WITH PROGESTERONE CREAM$677,301
R44 · FY2000 · AG
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2005 · HL
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2003 · HL
Coronary Reactivity and Thromboxane Receptor Expression$392,500
R01 · FY2002 · HL
Coronary Reactivity and Thromboxane Receptor Expression$353,250
R01 · FY2004 · HL
HORMONE REPLACEMENT THERAPY WITH PROGESTERONE CREAM$332,200
R44 · FY2000 · AG
ER beta selective agonist coronary protection--menopause$133,757
R43 · FY2003 · HL
HORMONE REPLACEMENT THERAPY WITH ESTRIOL SKIN CREAM$125,000
R43 · FY2000 · AG